Literature DB >> 28967230

Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.

Yao-Chi Chuang1, Shih-Ping Liu2, Kyu-Sung Lee3, Limin Liao4, Jianye Wang5, Tag Keun Yoo6, Romeo Chu7, Budiwan Sumarsono7.   

Abstract

OBJECTIVE: The aim of the present study was to determine the prevalence of overactive bladder (OAB) in individuals aged ≥40 years in China, Taiwan, and South Korea.
METHODS: The present cross-sectional population-representative Internet-based study investigated OAB symptoms in men and women aged ≥40 years using the overactive bladder symptom score. Additional instruments included the International Index of Erectile Function (men only) and the Sexual Quality of Life - Female (women only) questionnaires, as well as Patient Perception of Bladder Condition (PPBC).
RESULTS: In all, 8284 individuals participated in the study. The prevalence of OAB was 20.8% overall (women 22.1%, men 19.5%) and increased significantly with age, from 10.8% in those aged 40-44 years to 27.9% in those aged >60 years (P = .001). The presence of comorbid conditions (e.g. neurological disease, diabetes) was associated with a significantly increased prevalence of OAB. Increasing symptom severity was associated with significantly worsening patient perception of bladder condition responses. Just under half (48%) of those with no OAB had no lower urinary tract symptoms (LUTS), whereas 88% of those with severe symptoms had all 3 LUTS (International Continence Society definition) symptom categories (voiding, post-micturition, and storage symptoms). Of those without OAB, 10% reported visiting healthcare professionals for urinary symptoms, compared with 64% of those with severe OAB symptoms (P = .001). Increased symptom severity was significantly associated with lower sexual quality of life in both men and women.
CONCLUSIONS: OAB symptoms were found to affect 1 in 5 individuals aged ≥40 years in China, Taiwan, and South Korea, becoming more common with increasing age. The results suggest that many more individuals with OAB could benefit by consulting healthcare professionals.
© 2017 The Authors. LUTS Published by John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  China; Republic of Korea; Taiwan; overactive bladder; prevalence

Mesh:

Year:  2017        PMID: 28967230     DOI: 10.1111/luts.12193

Source DB:  PubMed          Journal:  Low Urin Tract Symptoms        ISSN: 1757-5664            Impact factor:   1.592


  28 in total

1.  Health-related quality of life in parous women with pelvic organ prolapse and/or urinary incontinence in Bangladesh.

Authors:  Atsuko Imoto; Malabika Sarker; Rahima Akter; Akiko Matsuyama; Sumihisa Honda
Journal:  Int Urogynecol J       Date:  2020-07-01       Impact factor: 2.894

2.  Efficacy and persistence of low-dose mirabegron (25 mg) in patients with overactive bladder: analysis in a real-world urological practice.

Authors:  Yuan Chi Shen; Hung Jen Wang; Yao Chi Chuang
Journal:  Int Urol Nephrol       Date:  2018-06-07       Impact factor: 2.370

3.  Inhibitory effects of a minimally invasive implanted tibial nerve stimulation device on non-nociceptive bladder reflexes in cats.

Authors:  Xiaoping Wan; Yanan Liang; Xing Li; Limin Liao
Journal:  Int Urol Nephrol       Date:  2020-09-28       Impact factor: 2.370

Review 4.  Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines.

Authors:  Abdullah Al-Danakh; Mohammed Safi; Mohammed Alradhi; Marwan Almoiliqy; Qiwei Chen; Murad Al-Nusaif; Xuehan Yang; Aisha Al-Dherasi; Xinqing Zhu; Deyong Yang
Journal:  Parkinsons Dis       Date:  2022-03-16

5.  Mirabegron is alternative to antimuscarinic agents for overactive bladder without higher risk in hypertension: a systematic review and meta-analysis.

Authors:  Hsiao-Ling Chen; Tun-Chieh Chen; Hsiu-Mei Chang; Yung-Shun Juan; Wei-Hsuan Huang; Hung-Fang Pan; Yong-Chieh Chang; Chiou-Mei Wu; Ya-Ling Wang; Hsiang Ying Lee
Journal:  World J Urol       Date:  2018-03-19       Impact factor: 4.226

Review 6.  Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants.

Authors:  Yi-Hsuan Wu; Kuang-Shun Chueh; Shu-Mien Chuang; Cheng-Yu Long; Jian-He Lu; Yung-Shun Juan
Journal:  Int J Mol Sci       Date:  2021-06-02       Impact factor: 5.923

7.  Association of decreased grip strength with lower urinary tract symptoms in women: a cross-sectional study from Korea.

Authors:  Su-Jin Yang; Jung Ha Park; Yunhwan Oh; Hyeonju Kim; Mihee Kong; Jihyun Moon
Journal:  BMC Womens Health       Date:  2021-03-04       Impact factor: 2.809

8.  NMDAR in bladder smooth muscle is not a pharmacotherapy target for overactive bladder in mice.

Authors:  Xiang Xie; Chuang Luo; Jia Yu Liang; Run Huang; Jia Li Yang; Linlong Li; YangYang Li; Hongming Xing; Huan Chen
Journal:  PeerJ       Date:  2021-07-07       Impact factor: 2.984

9.  Diagnostic Potential of Low Serum Platelet, Albumin and Prolong PT-INR for Overactive Bladder and Nocturia in Chronic Hepatitis-Related Liver Cirrhosis.

Authors:  Po-Heng Chuang; Yi-Huei Chang; Po-Jen Hsiao; Eric Chieh-Lung Chou
Journal:  J Clin Med       Date:  2021-06-27       Impact factor: 4.241

10.  Prevalence and associated risk factors among patients with overactive bladder syndrome in Pakistan.

Authors:  Sajid Rashid; Muhammad Naveed Babur; Rehan Ramzan Khan; Muhammad Usman Khalid; Haroon Mansha; Saima Riaz
Journal:  Pak J Med Sci       Date:  2021 Jul-Aug       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.